CD2H COVID-19

An Observational Clinical Study to Evaluate COVID-19 Symptoms in "Long Hauler" Patients Who Participated in K031-120 or K032-120

Purpose

This observational clinical study aims to evaluate the presence of symptoms of COVID-19 infection in patients who participated in K031-120 or K032-120 ("long hauler").

Condition

COVID-19

Eligibility

Eligible Ages: Over 18 Years
Eligible Genders: All
Accepts Healthy Volunteers: No

Inclusion Criteria

Have consented to participate over the telephone - Have been randomized in either the K031-120 or K032-120 study

Exclusion Criteria

Have withdrawn consent from K031-120 or K032-120

Study Design

Phase
Study Type: Observational
Observational Model: Cohort
Time Perspective: Prospective

Arm Groups

Arm	Description	Assigned Intervention
KB109 + Self Supportive Care (SSC)		Other: KB109 + Self Supportive Care KB109 is a novel glycan
Self Supportive Care (SSC) Alone		Other: Self Supportive Care (SSC) Alone Self Supportive Care (SSC) Alone

Recruiting Locations

More Details

NCT ID: NCT04814914
Status: Completed
Sponsor: Kaleido Biosciences

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.